Skip to content
OpenCapital
Get started

CryoPort, Inc. CYRX Concentration Risk %

Segments

By segment

See full
Life Sciences Services10.2%—

Other financials

Income statement

See full
Revenue$47.8M+16.5%
Gross profit$21.9M+17.6%
Operating income-$9.6M-33.6%
Net income-$10.5M+12.0%
EPS (diluted)-$0.25+10.7%

Balance sheet

See full
Cash & equivalents$272.9M+656%
Total debt$230.7M+293%
Total equity$495.0M+24.1%
Total assets$763.6M+9.1%

Cash flow

See full
Operating cash flow$3.7M+186%
CapEx$10.0M+215%
Free cash flow-$6.2M+16.8%

Valuation

See full
Market cap$800.39M+151%
Enterprise value$758.23M+122%
P/E10.6×—
P/S4.4×+2.4×

Profitability

See full
Gross margin47.2%+1.6pp
Operating margin-21.4%-8.8pp
Net margin39.2%+22.1pp
FCF margin-13%-3.6pp

Returns & leverage

See full
Return on equity14.5%+8.6pp
Debt / equity0.5×+0.3×
Current ratio2.1×-3.5×